{"hands_on_practices": [{"introduction": "A complete understanding of any metabolic pathway begins with its fundamental stoichiometry and energetic cost. This exercise challenges you to construct the net chemical equation for de novo UMP synthesis by systematically summing the individual enzymatic reactions, a core skill in metabolic analysis. By carefully tracking all reactants, products, and cofactors, including the ATP consumed, you will gain a quantitative appreciation for the material and energy investment required to build this essential nucleotide from simple precursors [@problem_id:2555137].", "problem": "In the cytosolic de novo pathway for pyrimidine biosynthesis in mammals, the pyrimidine ring is assembled before ribosylation. Starting only from first principles of the canonical enzymology of this pathway, derive the overall balanced chemical equation for the formation of uridine monophosphate (UMP) from glutamine, aspartate, bicarbonate, phosphoribosyl pyrophosphate (PRPP), and adenosine triphosphate (ATP). Your derivation must explicitly account for water, inorganic phosphate, inorganic pyrophosphate hydrolysis to orthophosphate, and carbon dioxide species. Assume the following mechanistic features are operative: bicarbonate (treated as $\\mathrm{HCO_3^-}$) is the carbon source for carbamoyl phosphate formation; dihydroorotate dehydrogenase uses a generic oxidized quinone (denote it as $\\mathrm{Q}$) to accept two reducing equivalents to form $\\mathrm{QH_2}$; and inorganic pyrophosphate released at any step is rapidly and completely hydrolyzed to orthophosphate by inorganic pyrophosphatase. \n\nThen, compute the net number of high-energy phosphate bonds (adenosine triphosphate equivalents) consumed under two scenarios:\n- $(i)$ PRPP is supplied exogenously and is available as a substrate.\n- $(ii)$ PRPP is synthesized in situ from ribose-5-phosphate by PRPP synthetase, which uses ATP.\n\nFor counting high-energy phosphate bonds, treat each cleavage of $\\mathrm{ATP} \\rightarrow \\mathrm{ADP} + \\mathrm{P_{i}}$ as consuming 1 high-energy bond and each cleavage of $\\mathrm{ATP} \\rightarrow \\mathrm{AMP} + \\mathrm{PP_{i}}$ as consuming 2 high-energy bonds. Present your final answer as a row matrix $\\begin{pmatrix} a  b \\end{pmatrix}$, where the first entry $a$ corresponds to scenario $(i)$ and the second entry $b$ corresponds to scenario $(ii)$. No rounding is required, and no units should be included in the final answer.", "solution": "The problem statement is a valid, well-posed problem in classical biochemistry. It is scientifically grounded, free of contradictions, and contains all necessary information to derive the chemical equation and compute the required energetic costs. The problem will be solved by a systematic, step-by-step analysis of the de novo pyrimidine biosynthesis pathway.\n\nThe first objective is to derive the overall balanced chemical equation for the synthesis of uridine monophosphate (UMP) from the specified precursors. The canonical pathway consists of six enzymatic reactions. We will write the balanced equation for each step and then sum them to obtain the net reaction. The problem specifies that inorganic pyrophosphate ($PP_i$) is completely hydrolyzed to orthophosphate ($P_i$), so the hydrolysis reaction must also be included.\n\nThe individual reactions are as follows:\n\n1.  **Carbamoyl Phosphate Synthetase II (CPS II)**: This enzyme catalyzes the formation of carbamoyl phosphate from bicarbonate, the amide nitrogen of glutamine, and two molecules of adenosine triphosphate (ATP). The reaction consumes one molecule of water to hydrolyze glutamine.\n    $$2 \\ \\mathrm{ATP} + \\mathrm{HCO_3^{-}} + \\mathrm{Glutamine} + \\mathrm{H_2O} \\rightarrow 2 \\ \\mathrm{ADP} + \\mathrm{P_i} + \\mathrm{Carbamoyl \\ Phosphate} + \\mathrm{Glutamate}$$\n\n2.  **Aspartate Transcarbamoylase (ATCase)**: Carbamoyl phosphate is condensed with aspartate to form N-carbamoylaspartate.\n    $$\\mathrm{Carbamoyl \\ Phosphate} + \\mathrm{Aspartate} \\rightarrow \\mathrm{N\\text{-}Carbamoylaspartate} + \\mathrm{P_i}$$\n\n3.  **Dihydroorotase**: This enzyme catalyzes an intramolecular condensation (cyclization) of N-carbamoylaspartate to form dihydroorotate, releasing a water molecule.\n    $$\\mathrm{N\\text{-}Carbamoylaspartate} \\rightarrow \\mathrm{Dihydroorotate} + \\mathrm{H_2O}$$\n\n4.  **Dihydroorotate Dehydrogenase**: Dihydroorotate is oxidized to orotate. The problem specifies that a generic quinone ($\\mathrm{Q}$) acts as the electron acceptor, becoming reduced to $\\mathrm{QH_2}$.\n    $$\\mathrm{Dihydroorotate} + \\mathrm{Q} \\rightarrow \\mathrm{Orotate} + \\mathrm{QH_2}$$\n\n5.  **Orotate Phosphoribosyltransferase (OPRT)**: The pyrimidine ring is attached to the ribose-5-phosphate moiety, which is provided by phosphoribosyl pyrophosphate (PRPP). This reaction forms orotidine 5'-monophosphate (OMP) and releases inorganic pyrophosphate ($PP_i$).\n    $$\\mathrm{Orotate} + \\mathrm{PRPP} \\rightarrow \\mathrm{OMP} + \\mathrm{PP_i}$$\n\n6.  **OMP Decarboxylase**: The final step is the decarboxylation of OMP to yield UMP and carbon dioxide ($\\mathrm{CO_2}$).\n    $$\\mathrm{OMP} \\rightarrow \\mathrm{UMP} + \\mathrm{CO_2}$$\n\nTo these six reactions, we must add the hydrolysis of pyrophosphate, as stipulated by the problem statement.\n\n7.  **Inorganic Pyrophosphatase**:\n    $$\\mathrm{PP_i} + \\mathrm{H_2O} \\rightarrow 2 \\ \\mathrm{P_i}$$\n\nNow, we sum these seven reactions. The intermediates that appear on both sides of the reaction series ($\\mathrm{Carbamoyl \\ Phosphate}$, $\\mathrm{N\\text{-}Carbamoylaspartate}$, $\\mathrm{Dihydroorotate}$, $\\mathrm{Orotate}$, $\\mathrm{OMP}$, and $\\mathrm{PP_i}$) will be canceled.\n\nSumming the left sides:\n$$(2 \\ \\mathrm{ATP} + \\mathrm{HCO_3^{-}} + \\mathrm{Gln} + \\mathrm{H_2O}) + (\\mathrm{Carb\\text{-}P} + \\mathrm{Asp}) + (\\mathrm{N\\text{-}Carb\\text{-}Asp}) + (\\mathrm{DHO} + \\mathrm{Q}) + (\\mathrm{Orotate} + \\mathrm{PRPP}) + (\\mathrm{OMP}) + (\\mathrm{PP_i} + \\mathrm{H_2O})$$\n\nSumming the right sides:\n$$(2 \\ \\mathrm{ADP} + \\mathrm{P_i} + \\mathrm{Carb\\text{-}P} + \\mathrm{Glu}) + (\\mathrm{N\\text{-}Carb\\text{-}Asp} + \\mathrm{P_i}) + (\\mathrm{DHO} + \\mathrm{H_2O}) + (\\mathrm{Orotate} + \\mathrm{QH_2}) + (\\mathrm{OMP} + \\mathrm{PP_i}) + (\\mathrm{UMP} + \\mathrm{CO_2}) + (2 \\ \\mathrm{P_i})$$\n\nAfter canceling the intermediates, we have:\nLeft: $2 \\ \\mathrm{ATP} + \\mathrm{HCO_3^{-}} + \\mathrm{Gln} + \\mathrm{Asp} + \\mathrm{Q} + \\mathrm{PRPP} + 2 \\ \\mathrm{H_2O}$\nRight: $2 \\ \\mathrm{ADP} + 4 \\ \\mathrm{P_i} + \\mathrm{Glu} + \\mathrm{QH_2} + \\mathrm{UMP} + \\mathrm{CO_2} + \\mathrm{H_2O}$\n\nFinally, we cancel one molecule of $\\mathrm{H_2O}$ from each side. The final, overall balanced chemical equation is:\n$$\\mathrm{Glutamine} + \\mathrm{Aspartate} + \\mathrm{HCO_3^{-}} + \\mathrm{PRPP} + 2 \\ \\mathrm{ATP} + \\mathrm{Q} + \\mathrm{H_2O} \\rightarrow \\mathrm{UMP} + \\mathrm{Glutamate} + 2 \\ \\mathrm{ADP} + 4 \\ \\mathrm{P_i} + \\mathrm{QH_2} + \\mathrm{CO_2}$$\n\nThe second objective is to compute the net number of high-energy phosphate bonds consumed in two scenarios. The cost is defined as $1$ bond for $\\mathrm{ATP} \\rightarrow \\mathrm{ADP} + \\mathrm{P_i}$ and $2$ bonds for $\\mathrm{ATP} \\rightarrow \\mathrm{AMP} + \\mathrm{PP_i}$.\n\n**(i) PRPP is supplied exogenously.**\nIn this scenario, we consider the pathway as derived above, where PRPP is a starting substrate. We inspect the overall balanced equation for ATP consumption. The equation shows the consumption of $2$ molecules of ATP, both of which are converted to ADP.\n$$2 \\ \\mathrm{ATP} \\rightarrow 2 \\ \\mathrm{ADP} + 2 \\ \\mathrm{P_i}$$\nThis occurs entirely within the CPS II reaction (Step $1$). According to the problem's definition, each $\\mathrm{ATP} \\rightarrow \\mathrm{ADP}$ cleavage consumes $1$ high-energy bond. Therefore, the total cost is $2 \\times 1 = 2$ high-energy bonds.\nThe value for $a$ is $2$.\n\n**(ii) PRPP is synthesized in situ.**\nIn this scenario, PRPP is not supplied but is synthesized from ribose-5-phosphate ($\\mathrm{R5P}$) and ATP. This reaction is catalyzed by PRPP synthetase.\n$$\\mathrm{Ribose\\text{-}5\\text{-}phosphate} + \\mathrm{ATP} \\rightarrow \\mathrm{PRPP} + \\mathrm{AMP}$$\nThis reaction involves the cleavage of ATP to AMP and the transfer of the pyrophosphoryl group to R5P. The cleavage of the phosphoanhydride bond between the $\\alpha$ and $\\beta$ phosphates of ATP is energetically costly. According to the problem's definition, this type of cleavage ($\\mathrm{ATP} \\rightarrow \\mathrm{AMP}$) consumes $2$ high-energy bonds.\nThe total cost for this scenario is the sum of the cost for UMP synthesis from PRPP (calculated in part (i)) and the cost of synthesizing PRPP itself.\nTotal Cost = (Cost from scenario (i)) + (Cost of PRPP synthesis)\n$$ \\text{Total Cost} = 2 + 2 = 4 $$\nThe value for $b$ is $4$.\n\nThe final answer is to be presented as a row matrix $\\begin{pmatrix} a  b \\end{pmatrix}$.\nThus, the matrix is $\\begin{pmatrix} 2  4 \\end{pmatrix}$.", "answer": "$$\\boxed{\\begin{pmatrix} 2  4 \\end{pmatrix}}$$", "id": "2555137"}, {"introduction": "While stoichiometry tells us what is consumed and produced, thermodynamics tells us why the pathway proceeds. The oxidation of dihydroorotate by DHODH is a critical, energy-yielding step coupled to the mitochondrial electron transport chain. This problem applies fundamental principles of redox thermodynamics to quantify the maximal driving force of this reaction under standard conditions [@problem_id:2555055]. By calculating the standard Gibbs free energy change from midpoint potentials, you will connect the flow of electrons to the overall spontaneity of pyrimidine biosynthesis.", "problem": "Dihydroorotate dehydrogenase (DHODH) catalyzes the oxidation of dihydroorotate to orotate in de novo pyrimidine biosynthesis, transferring electrons to membrane ubiquinone. Under biochemical standard conditions at pH $7.0$, the standard midpoint potential $E^\\circ{}'$ of the orotate/dihydroorotate redox couple (oxidized/reduced) is $-0.31\\,\\text{V}$, and the standard midpoint potential $E^\\circ{}'$ of the ubiquinone/ubiquinol redox couple is $+0.045\\,\\text{V}$. Assume the overall reaction transfers $n=2$ electrons per dihydroorotate oxidized. Use the Faraday constant $F = 96{,}485\\,\\text{C}\\,\\text{mol}^{-1}$.\n\nStarting from first principles of redox thermodynamics and standard-state definitions, determine the maximal thermodynamic driving force for DHODH under these standard conditions, expressed as the standard Gibbs energy change per mole of dihydroorotate oxidized. Express your final answer in $\\text{kJ}\\,\\text{mol}^{-1}$ and round to three significant figures. The sign of your result encodes the direction of electron flow under standard conditions.", "solution": "The problem requires the determination of the standard Gibbs energy change, $\\Delta G^\\circ{}'$, for the reaction catalyzed by dihydroorotate dehydrogenase (DHODH) under biochemical standard conditions. This quantity represents the maximal thermodynamic driving force of the reaction.\n\nFirst, the problem must be validated.\nGivens are extracted verbatim:\n- The reaction is the oxidation of dihydroorotate to orotate.\n- The electron acceptor is membrane ubiquinone.\n- Conditions are biochemical standard conditions at pH $7.0$.\n- The standard midpoint potential for the orotate/dihydroorotate couple is $E^\\circ{}'_{\\text{DHO/ORO}} = -0.31\\,\\text{V}$.\n- The standard midpoint potential for the ubiquinone/ubiquinol couple is $E^\\circ{}'_{\\text{Q/QH}_2} = +0.045\\,\\text{V}$.\n- The number of electrons transferred is $n=2$.\n- The Faraday constant is $F = 96{,}485\\,\\text{C}\\,\\text{mol}^{-1}$.\n\nThe problem is scientifically grounded, well-posed, and objective. It is based on fundamental principles of redox thermodynamics and uses realistic biochemical data. It contains all necessary information for a unique solution and has no internal contradictions or ambiguities. Therefore, the problem is valid and a solution will be constructed.\n\nThe fundamental relationship between the standard Gibbs energy change ($\\Delta G^\\circ{}'$) and the standard electromotive force or potential difference ($\\Delta E^\\circ{}'$) for a redox reaction is given by the equation:\n$$\n\\Delta G^\\circ{}' = -nF\\Delta E^\\circ{}'\n$$\nwhere $n$ is the number of moles of electrons transferred in the balanced reaction, and $F$ is the Faraday constant.\n\nThe overall reaction consists of two half-reactions. The direction of spontaneous electron flow is from the redox couple with the lower (more negative) standard potential to the couple with the higher (more positive) standard potential.\n\nThe two relevant half-reactions are:\n1.  Oxidation of dihydroorotate:\n    Dihydroorotate $\\rightarrow$ Orotate + $2H^+$ + $2e^-$\n    This corresponds to the orotate/dihydroorotate couple, for which the standard midpoint potential is given as $E^\\circ{}'_{\\text{DHO/ORO}} = -0.31\\,\\text{V}$. This couple serves as the electron donor.\n\n2.  Reduction of ubiquinone:\n    Ubiquinone (Q) + $2H^+$ + $2e^-$ $\\rightarrow$ Ubiquinol (QH$_2$)\n    This corresponds to the ubiquinone/ubiquinol couple, for which the standard midpoint potential is given as $E^\\circ{}'_{\\text{Q/QH}_2} = +0.045\\,\\text{V}$. This couple serves as the electron acceptor.\n\nThe standard potential difference for the overall reaction, $\\Delta E^\\circ{}'$, is calculated as the potential of the electron-accepting couple minus the potential of the electron-donating couple:\n$$\n\\Delta E^\\circ{}' = E^\\circ{}'_{(\\text{acceptor})} - E^\\circ{}'_{(\\text{donor})}\n$$\nSubstituting the given values:\n$$\n\\Delta E^\\circ{}' = E^\\circ{}'_{\\text{Q/QH}_2} - E^\\circ{}'_{\\text{DHO/ORO}} = (+0.045\\,\\text{V}) - (-0.31\\,\\text{V})\n$$\n$$\n\\Delta E^\\circ{}' = 0.045\\,\\text{V} + 0.31\\,\\text{V} = +0.355\\,\\text{V}\n$$\nA positive value for $\\Delta E^\\circ{}'$ confirms that the direction of electron flow from dihydroorotate to ubiquinone is spontaneous under standard conditions.\n\nNow, we can calculate the standard Gibbs energy change, $\\Delta G^\\circ{}'$, using the fundamental equation. We are given $n=2$ and $F = 96{,}485\\,\\text{C}\\,\\text{mol}^{-1}$.\n$$\n\\Delta G^\\circ{}' = -nF\\Delta E^\\circ{}'\n$$\nSubstituting the numerical values:\n$$\n\\Delta G^\\circ{}' = -(2) \\times (96{,}485\\,\\text{C}\\,\\text{mol}^{-1}) \\times (+0.355\\,\\text{V})\n$$\nThe unit Volt ($V$) is equivalent to Joules per Coulomb ($J\\,C^{-1}$). Therefore, the units combine as $(\\text{C}\\,\\text{mol}^{-1}) \\times (\\text{J}\\,\\text{C}^{-1}) = \\text{J}\\,\\text{mol}^{-1}$.\n$$\n\\Delta G^\\circ{}' = - (2 \\times 96{,}485 \\times 0.355)\\,\\text{J}\\,\\text{mol}^{-1}\n$$\n$$\n\\Delta G^\\circ{}' = -68{,}504.35\\,\\text{J}\\,\\text{mol}^{-1}\n$$\nThe problem requires the answer to be expressed in kilojoules per mole ($\\text{kJ}\\,\\text{mol}^{-1}$). We convert the units:\n$$\n\\Delta G^\\circ{}' = -68.50435\\,\\text{kJ}\\,\\text{mol}^{-1}\n$$\nFinally, we must round the result to three significant figures, as specified.\n$$\n\\Delta G^\\circ{}' \\approx -68.5\\,\\text{kJ}\\,\\text{mol}^{-1}\n$$\nThe negative sign indicates that the reaction is exergonic and proceeds spontaneously in the direction of dihydroorotate oxidation under standard biochemical conditions. This value represents the maximal thermodynamic driving force.", "answer": "$$\n\\boxed{-68.5}\n$$", "id": "2555055"}, {"introduction": "Modern biochemistry moves beyond static pathway maps to dynamically trace the flow of atoms in living cells. Stable isotope tracing is a cornerstone of this approach, allowing us to 'watch' as precursors are assembled into final products. This practice challenges you to think like an experimentalist, predicting the precise isotopic labeling pattern of UMP when cells are fed specific $^{13}\\mathrm{C}$ and $^{15}\\mathrm{N}$ tracers [@problem_id:2555097]. This exercise will sharpen your understanding of the pathway's atom-level construction and introduce you to the quantitative logic behind metabolic flux analysis.", "problem": "You are tasked with designing an isotopic tracing strategy to resolve the positional origins of atoms in the de novo biosynthesis of uridine 5'-monophosphate (UMP) and to predict the resulting mass isotopologue distribution under complete tracer labeling. Consider a mammalian cell system in which de novo pyrimidine biosynthesis is active and salvage is negligible. The cells are cultured in medium formulated as follows: the only source of inorganic carbon is uniformly labeled $^{13}\\mathrm{C}$-bicarbonate (100% atom $^{13}\\mathrm{C}$), the only source of glutamine is uniformly labeled $^{15}\\mathrm{N}$-glutamine (100% atom $^{15}\\mathrm{N}$), and all other nutrients (including aspartate and ribose precursors) are present at natural isotopic abundance and can be treated as effectively unlabeled for the purpose of this calculation. Assume complete incorporation of the carbons and nitrogens from these tracers at their respective biosynthetic entry points, and that the de novo pathway contributes exclusively to UMP production.\n\nUse the following well-tested mapping of atom origins in the pyrimidine ring synthesized de novo: the $N1$, $C4$, $C5$, and $C6$ atoms of the ring derive from aspartate; the $C2$ atom derives from inorganic carbon (bicarbonate/CO$_2$ via carbamoyl phosphate synthetase); and the $N3$ atom derives from the amide nitrogen of glutamine (via carbamoyl phosphate synthetase). The ribose phosphate moiety of UMP is derived from 5-phosphoribosyl-1-pyrophosphate and is unlabeled under these conditions.\n\nDefine the unit-mass isotopologue generating function for UMP with respect to the tracers as $G(x) = \\sum_{k=0}^{\\infty} p_{k} x^{k}$, where $p_{k}$ is the fraction of UMP molecules carrying exactly $k$ tracer-derived heavy isotopes (here counting only $^{13}\\mathrm{C}$ from bicarbonate and $^{15}\\mathrm{N}$ from glutamine). Under the conditions above and assuming complete labeling, determine $G(x)$.\n\nAdditionally, compute the exact monoisotopic mass shift $\\Delta m$ (in Daltons) for UMP relative to the unenriched monoisotopic composition that arises solely from the two tracer incorporations. Use the standard atomic mass differences $m(^{13}\\mathrm{C}) - m(^{12}\\mathrm{C}) = 1.003354835$ and $m(^{15}\\mathrm{N}) - m(^{14}\\mathrm{N}) = 0.997034895$ and assume all other atoms remain at their monoisotopic light masses. Round your numerical answer for $\\Delta m$ to six significant figures. Express the final mass shift in Daltons.\n\nReport your final answer as a two-entry row, $\\begin{pmatrix} G(x)  \\Delta m \\end{pmatrix}$, in that order.", "solution": "The problem statement presented is scientifically grounded, well-posed, and objective. It describes a standard isotopic tracing experiment in biochemistry. The atom origins for the de novo pyrimidine biosynthetic pathway are correctly stated according to established biochemical knowledge. The conditions for labeling are specified without ambiguity, and the required calculations are clearly defined. Therefore, the problem is valid and a rigorous solution can be derived.\n\nThe task is to determine two quantities for uridine 5'-monophosphate (UMP) synthesized de novo under specific isotopic labeling conditions: the isotopologue generating function $G(x)$ and the monoisotopic mass shift $\\Delta m$.\n\nFirst, we must identify which atoms in the UMP molecule become labeled. UMP is composed of a pyrimidine base (uracil), a ribose sugar, and a phosphate group. The problem provides the following information about the origins of the atoms in the pyrimidine ring and their labeling status:\n\\begin{itemize}\n    \\item Atoms $N1$, $C4$, $C5$, and $C6$ are derived from aspartate. Aspartate is provided as unlabeled. Therefore, these atoms remain at their natural light isotopic state, primarily $^{14}\\mathrm{N}$ and $^{12}\\mathrm{C}$.\n    \\item Atom $C2$ is derived from inorganic carbon, which is supplied as $100\\%$ $^{13}\\mathrm{C}$-bicarbonate. Consequently, the $C2$ atom of every newly synthesized uracil ring will be a $^{13}\\mathrm{C}$ isotope.\n    \\item Atom $N3$ is derived from the amide nitrogen of glutamine. Glutamine is supplied as $100\\%$ uniformly $^{15}\\mathrm{N}$-labeled. The enzyme carbamoyl phosphate synthetase II utilizes the amide nitrogen of glutamine for this reaction. Thus, the $N3$ atom of every newly synthesized uracil ring will be a $^{15}\\mathrm{N}$ isotope.\n    \\item The ribose phosphate moiety is explicitly stated to be derived from unlabeled precursors.\n\\end{itemize}\nThe problem states that labeling from the specified tracers is complete and that the de novo pathway is the exclusive source of UMP. This means that every UMP molecule produced will deterministically contain exactly one $^{13}\\mathrm{C}$ atom (at position $C2$) and one $^{15}\\mathrm{N}$ atom (at position $N3$) originating from the tracers.\n\nThe generating function $G(x)$ is defined as $G(x) = \\sum_{k=0}^{\\infty} p_{k} x^{k}$, where $p_{k}$ is the fraction of UMP molecules carrying exactly $k$ tracer-derived heavy isotopes. The tracers to be counted are specified as $^{13}\\mathrm{C}$ from bicarbonate and $^{15}\\mathrm{N}$ from glutamine.\nBased on our analysis, the number of heavy isotopes incorporated per UMP molecule is $k = 1$ (from $^{13}\\mathrm{C}$) $+ 1$ (from $^{15}\\mathrm{N}$) $= 2$.\nSince labeling is complete and exclusive, the population of UMP molecules is homogeneous with respect to these labels. The probability distribution $p_k$ is a Kronecker delta function centered at $k=2$:\n$$ p_k = \\begin{cases} 1  \\text{if } k=2 \\\\ 0  \\text{if } k \\neq 2 \\end{cases} $$\nSubstituting this distribution into the definition of the generating function gives:\n$$ G(x) = \\sum_{k=0}^{\\infty} p_{k} x^{k} = p_{0}x^{0} + p_{1}x^{1} + p_{2}x^{2} + \\dots = (0)(1) + (0)(x) + (1)(x^{2}) + (0)(x^{3}) + \\dots $$\n$$ G(x) = x^{2} $$\n\nNext, we calculate the exact monoisotopic mass shift, $\\Delta m$. This is the difference between the mass of the labeled UMP molecule and its corresponding unlabeled counterpart, considering only the incorporated heavy isotopes. The shift is the sum of the mass differences for each incorporated heavy isotope relative to its light stable isotope.\nOne $^{13}\\mathrm{C}$ atom replaces a $^{12}\\mathrm{C}$ atom, and one $^{15}\\mathrm{N}$ atom replaces a $^{14}\\mathrm{N}$ atom. The total mass shift is:\n$$ \\Delta m = \\left( m(^{13}\\mathrm{C}) - m(^{12}\\mathrm{C}) \\right) + \\left( m(^{15}\\mathrm{N}) - m(^{14}\\mathrm{N}) \\right) $$\nThe problem provides the necessary mass differences:\n$$ m(^{13}\\mathrm{C}) - m(^{12}\\mathrm{C}) = 1.003354835 \\text{ Da} $$\n$$ m(^{15}\\mathrm{N}) - m(^{14}\\mathrm{N}) = 0.997034895 \\text{ Da} $$\nSumming these values yields the total mass shift:\n$$ \\Delta m = 1.003354835 \\text{ Da} + 0.997034895 \\text{ Da} = 2.00038973 \\text{ Da} $$\nThe problem requires this value to be rounded to six significant figures. The calculated value is $2.00038973$. The first six significant figures are $2$, $0$, $0$, $0$, $3$, $8$. The seventh digit is $9$, so we round up the sixth digit ($8$) to $9$.\nTherefore, the rounded mass shift is:\n$$ \\Delta m \\approx 2.00039 \\text{ Da} $$\nThe two results, $G(x)$ and $\\Delta m$, form the complete answer.", "answer": "$$\\boxed{\\begin{pmatrix} x^{2}  2.00039 \\end{pmatrix}}$$", "id": "2555097"}]}